Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 29, 2018 - TherapeuticsMD announced the FDA approval of Bijuva (estradiol/progesterone), for the treatment of moderate to severe vasomotor symptoms due to menopause in women with a uterus.
Return to publications